Adrian Moore

4.3k total citations · 1 hit paper
78 papers, 3.2k citations indexed

About

Adrian Moore is a scholar working on Rheumatology, Molecular Biology and Immunology. According to data from OpenAlex, Adrian Moore has authored 78 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Rheumatology, 22 papers in Molecular Biology and 20 papers in Immunology. Recurrent topics in Adrian Moore's work include Osteoarthritis Treatment and Mechanisms (25 papers), Inflammatory mediators and NSAID effects (14 papers) and Cell Adhesion Molecules Research (11 papers). Adrian Moore is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (25 papers), Inflammatory mediators and NSAID effects (14 papers) and Cell Adhesion Molecules Research (11 papers). Adrian Moore collaborates with scholars based in United Kingdom, United States and Italy. Adrian Moore's co-authors include D. A. Willoughby, Dean Willis, Ronnie O. Frederick, Paul Colville‐Nash, D. A. Willoughby, Derek W. Gilroy, Kevin Greenslade, Martyn K. Robinson, Massimo Marenzana and Mauro Perretti and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Adrian Moore

78 papers receiving 3.1k citations

Hit Papers

Heme oxygenase: A novel t... 1996 2026 2006 2016 1996 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Adrian Moore 1.6k 559 520 389 317 78 3.2k
Paul Colville‐Nash 1.9k 1.2× 1.2k 2.2× 1.5k 2.9× 248 0.6× 480 1.5× 52 5.0k
Teruto Hashiguchi 1.1k 0.7× 781 1.4× 493 0.9× 105 0.3× 344 1.1× 131 4.0k
Laurent Baud 1.3k 0.8× 775 1.4× 226 0.4× 137 0.4× 519 1.6× 115 3.8k
Su Wol Chung 2.5k 1.5× 753 1.3× 311 0.6× 85 0.2× 303 1.0× 77 4.3k
Mark J. Paul‐Clark 1.5k 0.9× 1.1k 2.0× 788 1.5× 133 0.3× 461 1.5× 50 3.5k
Dennis A. Priebat 998 0.6× 820 1.5× 305 0.6× 417 1.1× 413 1.3× 37 5.2k
Yukie Niwa 681 0.4× 573 1.0× 234 0.5× 163 0.4× 258 0.8× 77 2.7k
Kenneth S. Kilgore 767 0.5× 742 1.3× 485 0.9× 719 1.8× 538 1.7× 57 3.3k
Li‐Der Hsiao 1.3k 0.8× 512 0.9× 304 0.6× 124 0.3× 316 1.0× 86 2.6k
Keiko Suzuki 808 0.5× 301 0.5× 149 0.3× 458 1.2× 198 0.6× 191 2.7k

Countries citing papers authored by Adrian Moore

Since Specialization
Citations

This map shows the geographic impact of Adrian Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian Moore more than expected).

Fields of papers citing papers by Adrian Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrian Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian Moore. The network helps show where Adrian Moore may publish in the future.

Co-authorship network of co-authors of Adrian Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Adrian Moore. A scholar is included among the top collaborators of Adrian Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrian Moore. Adrian Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rhys, Hefin, Francesco Dell’Accio, Costantino Pitzalis, et al.. (2018). Neutrophil Microvesicles from Healthy Control and Rheumatoid Arthritis Patients Prevent the Inflammatory Activation of Macrophages. EBioMedicine. 29. 60–69. 90 indexed citations
2.
Greco, Karin Vicente, Sarah E. Headland, Trinidad Montero‐Melendez, et al.. (2017). Identification of Novel Chondroprotective Mediators in Resolving Inflammatory Exudates. The Journal of Immunology. 198(7). 2876–2885. 8 indexed citations
3.
Kevorkian, Lara, et al.. (2014). A modified and enhanced atdc5 chondrogenesis model produces an articular-like phenotype. Osteoarthritis and Cartilage. 22. S169–S169. 2 indexed citations
4.
Shaw, Stevan, Tim Bourne, Chris Meier, et al.. (2014). Discovery and characterization of olokizumab. mAbs. 6(3). 773–781. 70 indexed citations
5.
Greco, Karin Vicente, Asif Iqbal, Lorenza Rattazzi, et al.. (2011). High density micromass cultures of a human chondrocyte cell line: A reliable assay system to reveal the modulatory functions of pharmacological agents. Biochemical Pharmacology. 82(12). 1919–1929. 51 indexed citations
6.
Marenzana, Massimo, et al.. (2011). Sclerostin antibody treatment enhances bone strength but does not prevent growth retardation in young mice treated with dexamethasone. Arthritis & Rheumatism. 63(8). 2385–2395. 62 indexed citations
7.
Moore, Adrian, Samir S. Ayoub, & Michael Seed. (2010). Cyclooxygenase Enzymes and Their Products in the Carrageenan-Induced Pleurisy in Rats. Methods in molecular biology. 644. 201–205. 4 indexed citations
8.
Groundwater, Paul W., et al.. (2009). An overview of cancer treatments. Pharmaceutical journal/˜The œpharmaceutical journal. 283(7577). 511–512. 4 indexed citations
10.
Colville‐Nash, Paul, Derek W. Gilroy, Dean Willis, et al.. (2005). Prostaglandin F2α produced by inducible cyclooxygenase may contribute to the resolution of inflammation. Inflammopharmacology. 12(5-6). 473–476. 13 indexed citations
11.
Moore, Adrian. (2003). Pleural Models of Inflammation Immune and Nonimmune. Humana Press eBooks. 225. 123–128. 29 indexed citations
12.
Moore, Adrian. (2003). Collagen-Induced Arthritis. Humana Press eBooks. 225. 175–180. 8 indexed citations
13.
Willoughby, D. A., Adrian Moore, Paul Colville‐Nash, & Derek W. Gilroy. (2000). Resolution of inflammation. International Journal of Immunopharmacology. 22(12). 1131–1135. 168 indexed citations
14.
Moore, Adrian, Kazuhito Kawabata, José António Pereira da Silva, et al.. (1999). Destruction of articular cartilage by alpha2macroglobulin elastase complexes: role in rheumatoid arthritis. Annals of the Rheumatic Diseases. 58(2). 109–113. 27 indexed citations
15.
Moore, Adrian, et al.. (1997). Oral dosing of rats with OM-89 results in the appearance of specific OM-89 antibodies of the IgG2a isotype: possible significance in the treatment of rheumatoid arthritis. International Journal of Immunopharmacology. 19(9-10). 569–572. 3 indexed citations
16.
Moore, Adrian & D. A. Willoughby. (1995). Hyaluronan as a drug delivery system for diclofenac: a hypothesis for mode of action.. PubMed. 17(4). 153–6. 48 indexed citations
17.
Willis, Dean, Adrian Moore, G. Gowland, & D. A. Willoughby. (1995). OM-89 MODULATION OF CHRONIC INFLAMMATION: RELEVANCE TO CLINICAL USE. Lara D. Veeken. 34(6). 525–528. 5 indexed citations
18.
IWAMURA, H., Adrian Moore, & D. A. Willoughby. (1993). Interaction between neutrophil-derived elastase and reactive oxygen species in cartilage degradation. Biochimica et Biophysica Acta (BBA) - General Subjects. 1156(3). 295–301. 42 indexed citations
19.
Salvemini, Daniela, Waldemar Radziszewski, Vincenzo Mollace, et al.. (1991). Diphenylene iodonium, an inhibitor of free radical formation, inhibits platelet aggregation. European Journal of Pharmacology. 199(1). 15–18. 45 indexed citations
20.
Edwards, Jo C. W., Anne Cooke, Adrian Moore, et al.. (1986). Connective tissue abnormalities in MRL/1 mice.. Annals of the Rheumatic Diseases. 45(6). 512–518. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026